Outils personnels
Vous êtes ici : Accueil Métab'Est Recherche Publications 2009
Actions sur le document


77.  Optimizing the use of sapropterin (BH(4)) in the management of phenylketonuria. BLAU N, BELANGER-QUINTANA A, DEMIRKOL M, FEILLET, F ET AL. Mol Genet Metab 2009.


78.  24 month-treatment with miglustat of three patients with Niemann-Pick disease type C: follow up using brain spectroscopy. GALANAUD D, TOURBAH A, LEHERICY S, FEILLET, F ET AL. Mol Genet Metab 2009;96(2):55-8.


79.  Contrast-enhanced ultrasonography in patients with glycogen storage disease type Ia and adenomas. NGUYEN AT, BRESSENOT A, MANOLÉ S, GALLOY MA, BRONOWICKI JP, VIDAILHET M, FEILLET F, CLAUDON M. J Ultrasound Med. 2009 Apr;28(4):497-505.


80.  Contrast-enhanced ultrasonography in patients with glycogen storage disease type Ia and adenomas. NGUYEN AT, BRESSENOT A, MANOLÉ S, GALLOY MA, BRONOWICKI JP, VIDAILHET M, FEILLET F, CLAUDON M.J Ultrasound Med. 2009 Apr;28(4):497-505.


81.  Diagnosis and management of hyperammonemia. BONNEMAINS C, FEILLET F. Arch Pediatr. 2009 Jun;16(6):634-6. French. No abstract available.


82.  Management of phenylketonuria in Europe: Survey results from 19 countries. BLAU N, BÉLANGER-QUINTANA A, DEMIRKOL M, FEILLET F, GIOVANNINI M, MACDONALD A, TREFZ FK, SPRONSEN FV; contributing European PKU centers. Mol Genet Metab. 2009 Sep 13.


83.  GARNOTEL, R. Les maladies métaboliques de l’adulte : savoir y penser !Journées Nationales de Biologie Clinique de la Société Tunisienne de Biologie      Clinique, Sousse, mai 2009


84.  GARNOTEL, R. Les maladies métaboliques de l’adulte : savoir y penser !  Rev. Tunis. Biol. Clin., 2009, 22, suppl mai 2009, 32.


85.  DAVAL JL, BLAISE SA, GUEANT JL. Vitamin B12 deficiency causes neural cell loss and cognitive impairment in the developing rat. Proc. Natl Acad. Sci. USA, 2009, 106, E1


86.  BLAISE SA, NEDELEC E, ALBERTO JM, SCHROEDER H, AUDONNET S, BOSSENMEYER-POURIE C, GUEANT JL, DAVAL JL. Short hypoxia could attenuate the adverse effects of hyperhomocysteinemia on the developing rat brain by inducing neurogenesis..Exp. Neurol., 2009, 216, 231-238


87.  SPADA RS, STELLA G, CALABRESE S, BOSCO P, ANELLO G, GUEANT-RODRIGUEZ  RM, ROMANO A, BENAMGHAR L, GUEANT JL. Prevalence of dementia in mountainous village of Sicily. J. Neurol. Sci., 2009, 283, 62-65


88.  PONS L, BATTAGLIA-HSU S, OROZCO-BARRIOS C, ORTIOU S, CHERY C, ALBERTO JM, ARANGO-RODRIGUEZ ML, MARTINEZ-FONG D, FREUND JN, GUEANT JL Anchoring Secreted Proteins in Endoplasmic Reticulum by Plant Oleosin: the Example of Vitamin B12 Cellular Sequestration by Transcobalamin Plos One, 2009, 4, e6325


89.  AKCHICHE N, BOSSENMEYER-POURIE C, POURIE G, KOZIEL V, NEDELEC E, GUEANT JL, DAVAL JL. Differenciation and neural integration of hippocampal neuronal progenitors : signaling pathways sequentially involved. Hippocampus, 2009, in press


90.  SAADJIAN AY, GEROLAMI V, GIORGI R, MERCIERL, BERGE-LEFRANC JL, PAGANELLI F, IBRAHIM Z, BY Y, GUEANT JL, LEVY S, GUIEU RP.Head-up tilt induced syncope and adenosine A2A receptor gene polymorphism. Eur. Heart J., 2009, 30, 1510-1515


Time course gene expression in the one-carbon metabolism network using HepG2 cell oine grown in folate-deficient medium. J. Nutr. Biochem., 2009, 20, 312-320


92.  BOSSENMEYER-POURIE C, BLAISE S, POURIE G, TOMASETTO C, AUDONNET S, ORTIOU S, KOZIEL V, RIO MC, DAVAL JL, GUEANT JL; BECK B. Methyl donor deficiency affects fetal programming of gastric ghrelin cell organization and function in the rat. Am. J. Pathol., in press.


93.  HSU-BATTAGLIA SF, AKCHICHE N, NOEL N, ALBERTO JM, JEANNESSON E, DAVAL JL, GUEANT JL . Vitamin B12 deficiency reduces proliferation and promotes differentiation of neuroblastoma cells and upregulates PP2A, proNGF and TACE. Proc Natl Acad Sci U S A, 2009, in press.


Prevalence of hepatitis B and C and risk factors for non-vaccination in inflammatory bowel disease patients in the Nort-East of France. Inflamm. Bowel Dis., 2009, soumis


95.  Tubulopathy and pancytopaenia with normal pancreatic function: a variant of Pearson syndrome.ATALE A, BONNEAU-AMATI P, RÖTIG A, FISCHER A, PEREZ-MARTIN S, DE LONLAY P, NIAUDET P, DE PARSCAU L, MOUSSON C, THAUVIN-ROBINET C, MUNNICH A, HUET F, FAIVRE L. Eur J Med Genet. 2009 Jan-Feb;52(1):23-6.


96.  GROBOIS B, ROSE C, NOEL E, DE ROUX SERRATRICE C, DOBBELAERE D, GRESSIN V, CHERIN P, HARTMANN A, JAVIER RM, CLERSON P, HACHULLA E, JAUSSAUD R. Gaucher disease and monoclonal gammopathy : a report of 17 cases and impact of therapy. Blood Cells, Molecules, and Diseases 2009;43:138-9.

97. Minana-Solis MC, Angeles-Castellanos M, Feillet C, Pevet P, Challet E, Escobar C. Differential effects of a restricted feeding schedule on clock-gene expression in the hypothalamus of the rat. Chronobiol Int. 2009 Jul;26(5):808-20.

98. Orozco-Barrios CE, Battaglia-Hsu SF, Arango-Rodriguez ML, Ayala-Davila J, Chery C, Alberto JM, et al. Vitamin B12-impaired metabolism produces apoptosis and Parkinson phenotype in rats expressing the transcobalamin-oleosin chimera in substantia nigra. PLoS One. 2009;4(12):e8268.

99. Mehta A, Beck M, Elliott P, Giugliani R, Linhart A, Sunder-Plassmann G, et al. Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data. Lancet. 2009 Dec 12;374(9706):1986-96.

100. Cherin P, Rose C, de Roux-Serratrice C, Tardy D, Dobbelaere D, Grosbois B, et al. The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG). J Inherit Metab Dis. 2010 Aug;33(4):331-8.

« Mai 2019 »
Di Lu Ma Me Je Ve Sa
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Réalisé avec le CMS Plone, le système de gestion de contenu Open Source

Ce site respecte les normes suivantes :